A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum Calcium, -magnesium and -phosphate in Type 2 diabetes and non-diabetes metabolism
Open Access
- 1 January 2011
- journal article
- Published by Springer Science and Business Media LLC in Cardiovascular Diabetology
- Vol. 10 (1), 116
- https://doi.org/10.1186/1475-2840-10-116
Abstract
This study investigates the associations between changes in serum Triglycerides (S-TG), -Urate (S-Urate), and -Glucose (S-Glu) and changes in serum Calcium (S-Ca), -Magnesium (S-Mg), and -Phosphate (S-P) in patients with type 2 diabetes compared with non-diabetic patients. The analysis is based on data collected from a secondary prevention population of women and men (W/M) at risk for cardiovascular disease (type 2 diabetes, 212/200; non-diabetes 968/703). The whole population (n = 2083) had a mean age of 51.0 (9.7) years and was stratified for sex and according to type 2 diabetes or non-diabetes. The patients were followed for, either half a year or one year and changes in risk factors were calculated from follow-up to baseline, the time when patients were admitted to the health center. The pattern of relationships was evaluated using a structural equation model. Higher S-TG and S-Glu but lower S-Urate was revealed at baseline in type 2 diabetes women and men as compared to their counterparts, non-diabetes patients. Women with type 2 diabetes had higher S-Ca and lower S-Mg than non-diabetes women. Changes in S-Glu were associated with changes in S-Ca (+), baseline S-Ca (+), and S-Urate (-) in type 2 diabetes men. Changes in S-Urate were associated with changes in S-Mg (+) in type 2 diabetes women and non-diabetes men. In men with non-diabetes, changes in S-Glu were associated with changes in S-Mg (-). In women with non-diabetes, changes in S-Glu were associated with changes in S-P (-) and changes in S-Urate with changes in S-Ca (+). With respect to metabolic disturbances in non-diabetes and the awareness of risk for type 2 diabetes, changes in S-Glu and changes in S-Ca, S-Mg, and S-P should be considered as risk factors for cardiovascular disease. Increased early detection and corrections of high S-Ca, low S-Mg, and S-P in obese patients may improve their metabolism and reduce the risk of CVD in patients with type 2 diabetes. ISRCTN: ISRCTN79355192Keywords
This publication has 33 references indexed in Scilit:
- Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetesCardiovascular Diabetology, 2011
- Cross-Sectional Evidence of a Signaling Pathway from Bone Homeostasis to Glucose MetabolismJournal of Clinical Endocrinology & Metabolism, 2011
- Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional studyCardiovascular Diabetology, 2011
- Prediction model for high glycated hemoglobin concentration among ethnic Chinese in TaiwanCardiovascular Diabetology, 2010
- Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional studyCardiovascular Diabetology, 2009
- Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate,-calcium and-magnesiumActa Diabetologica, 2007
- Serum calcium and survival in a large health screening programJournal of Clinical Endocrinology & Metabolism, 1996
- Phosphate depletion impairs insulin secretion by pancreatic isletsKidney International, 1991
- Cardiovascular consequences of magnesium deficiency and loss: Pathogenesis, prevalence and manifestations—Magnesium and chloride loss in refractory potassium repletionThe American Journal of Cardiology, 1989
- Serum Inorganic Phosphate and Serum Calcium in Middle‐Aged MenActa Medica Scandinavica, 1978